Request Demo
Last update 23 Jan 2025
BMS-770767
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 11β-HSD inhibitors(11-beta-hydroxysteroid dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC19H18ClN3O2 |
InChIKeyHNXGIFYHJKEXNA-UHFFFAOYSA-N |
CAS Registry1875067-34-7 |
Related
2
Clinical Trials associated with BMS-770767NCT01058083
A Double-blind, Placebo-Controlled, Parallel-Group, Randomized, Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Primary Hypercholesterolemia
NCT01046422
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
100 Clinical Results associated with BMS-770767
Login to view more data
100 Translational Medicine associated with BMS-770767
Login to view more data
100 Patents (Medical) associated with BMS-770767
Login to view more data
1
Literatures (Medical) associated with BMS-77076701 Dec 2016Journal of Labelled Compounds and RadiopharmaceuticalsQ4 · MEDICINE
The synthesis and analysis of [phenyl‐14C(U)]BMS‐770767 and [13C6]BMS‐770767 for use in discovery biotransformation, human ADME and bioanalytical studies
Q4 · MEDICINE
Article
Author: Maxwell, Brad D. ; Bonacorsi, Samuel J.
100 Deals associated with BMS-770767
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | KR | 01 May 2010 | |
| Diabetes Mellitus, Type 2 | Phase 2 | AU | 01 May 2010 | |
| Diabetes Mellitus, Type 2 | Phase 2 | CA | 01 May 2010 | |
| Diabetes Mellitus, Type 2 | Phase 2 | US | 01 May 2010 | |
| Primary hypercholesterolemia | Phase 2 | AU | 01 May 2010 | |
| Primary hypercholesterolemia | Phase 2 | CA | 01 May 2010 | |
| Primary hypercholesterolemia | Phase 2 | US | 01 May 2010 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free